Protocol - Self-reported Exposure to and Use of Price Promotions for Tobacco Products
- Self-reported Exposure to Tobacco Product Advertisements
- Self-reported Exposure to Tobacco Product Sponsorships
- Self-reported Tobacco Product Price Paid - Cigarettes
- Self-reported Tobacco Product Price Paid - Cigars
- Self-reported Tobacco Product Price Paid - E-Cigarettes
- Self-reported Tobacco Product Price Paid - Smokeless Tobacco
- Self-reported Tobacco Product Purchase Location - Cigarettes
- Self-reported Tobacco Product Purchase Location - Cigars
- Self-reported Tobacco Product Purchase Location - E-Cigarettes
- Self-reported Tobacco Product Purchase Location - Hookah Tobacco
- Self-reported Tobacco Product Purchase Location - Pipe
- Self-reported Tobacco Product Purchase Location - Smokeless Tobacco
Description
This protocol includes 4 questions taken from the Wave 7 Adult and Youth Population Assessment of Tobacco and Health (PATH) Survey instruments. Collectively, the questions are used to measure consumer exposure to tobacco-product price promotions, including (but not limited to) lower price paid or free tobacco products, discounted prices when buying multiple tobacco product units, and free or discounted tobacco product with purchase of tobacco products.
Specific Instructions
This protocol was systematically updated to reflect the Wave 7 data collection of the Population Assessment of Tobacco and Health (PATH) Study. This protocol will be formally reviewed by a TRR Content Expert Panel early in 2024.
The Working Group (WG) recommends the following:
- Questions from both the Youth and Adult Population Assessment of Tobacco and Health (PATH) questionnaires are included in this protocol, and the WG believes that questions may be asked of all respondents (12 years of age and up).
- To answer Question 4, investigators will need to determine whether a respondent has a regular brand of tobacco. To do so, the WG is recommending that investigators add the Use of a Regular Brand of Tobacco Toolkit measure.
In addition, the WG recommends that investigators consider CLEARLY defining "tobacco products" BY NOTING WHETHER THAT DEFINITION INCLUDES OR EXCLUDES certain types of related products BASED ON THESE CRITERIA: products that are intended for human consumption; typically contain nicotine, which may or may not be derived from tobacco, but sometimes do not; and are not Food and Drug Administration-approved tobacco cessation products.
Determine electronic nicotine product use status prior to administration.
EPRODFILL2 = type of electronic nicotine product endorsed using
Availability
Protocol
1. In the past 12 months, have you received discounts or coupons for any of the following products? Choose all that apply.
1[ ]Cigarettes
2[ ]E-cigarettes or other electronic nicotine products (including e-liquid)
10[ ]Traditional cigars
11[ ]Cigarillos
12[ ]Filtered cigars
4[ ]Shisha or hookah tobacco
5[ ]Snus
6[ ]Smokeless tobacco (such as moist snuff, dip, spit, or chew)
7[ ]IQOS
13[ ]Nicotine pouches (such as Zyn, on!, or Velo)
14[ ]Other types of oral nicotine products (such as Velo lozenges, Rogue tablets, Lucy gum, or Pixotine toothpicks)
8[ ]Some other type of product
9[ ]None of the above
-8[ ]DON’T KNOW
-7[ ]REFUSED
ASK: All respondents
2. In the past 30 days, have you used a discount coupon or promotion to purchase a tobacco product?
1[ ]Yes
2[ ]No
-8[ ]DON’T KNOW
-7[ ]REFUSED
ASK: Respondents who have received a discount coupon or promotion.
3. In the past 30 days, how often have you used a coupon when buying [EPRODFILL2]?
1[ ]Always
2[ ]Sometimes
3[ ]Rarely
4[ ]Never
-8[ ]DON’T KNOW
-7[ ]REFUSED
ASK: Respondents who report past 30-day e-cigarette/electronic nicotine product use.
4. In the past 30 days, how many times have you bought a brand of tobacco product because you noticed a promotion for it?
1[ ]0 times
2[ ]Once or twice
3[ ]A few times
4[ ]Many times
-8[ ]DON’T KNOW
-7[ ]REFUSED
ASK: Current tobacco users who use a product for which they do not have a regular brand.
Personnel and Training Required
None
Equipment Needs
None
Requirements
| Requirement Category | Required |
|---|---|
| Major equipment | No |
| Specialized training | No |
| Specialized requirements for biospecimen collection | No |
| Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered or interviewer-administered questionnaire
Lifestage
Child, Adolescent, Adult
Participants
Adult (18+) and youth (12-17)
Selection Rationale
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products, and those at risk for tobacco use across the United States. Respondents 12 years old and up are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
Language
English, Other languages available at source
Standards
| Standard | Name | ID | Source |
|---|
Derived Variables
None
Process and Review
Not applicable.
Protocol Name from Source
Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview and Final Youth Interview, Wave 7 (January 2022 - December 2022)
Source
National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. Final_PATH_Wave_7_English_Adult_Questionnaire.pdf
National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Youth Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. Final_PATH_Wave_7_English_Youth_Questionnaire.pdf
General References
National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. Final_PATH_Wave_7_English_Adult_Questionnaire.pdf
National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Youth Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. Final_PATH_Wave_7_English_Adult_Questionnaire.pdf
Protocol ID
740402
Variables
Export Variables| Variable Name | Variable ID | Variable Description | dbGaP Mapping |
|---|
Measure Name
Self-reported Exposure to and Use of Price Promotions for Tobacco Products
Release Date
December 22, 2023
Definition
Instrument used to assess exposure to tobacco-product price promotions, including (but not limited to) lower price paid or free tobacco products, discounted prices when buying multiple tobacco product units, and free or discounted tobacco product with purchase of tobacco products.
Purpose
The purpose of this measure is to assess self-reported consumer observations of tobacco-product price promotions and the use of price promotions.
Keywords
self-reported exposure to and use of price promotions for tobacco products, Tobacco product advertisements, tobacco, product advertisements, Advertisements, marketing, cigarette products, price promotion, promotions, Population Assessment of Tobacco and Health Study, PATH, electronic nicotine products
Measure Protocols
| Protocol ID | Protocol Name |
|---|---|
| 740402 | Self-reported Exposure to and Use of Price Promotions for Tobacco Products |
Publications
There are no publications listed for this protocol.